Neonatal screening for cystic fibrosis


Autoria(s): Bowling, F.; Cleghorn, G.J.; Chester, A.; Curran, J.; Griffin, B.; Prado, J.; Francis, P.; Shepherd, R.
Data(s)

1988

Resumo

Two groups of patients with cystic fibrosis were compared. The screened group, detected with an improved neonatal screening assay for immunoreactive trypsin, developed fewer chest infections requiring treatment and gained more weight than the unscreened group. Early diagnosis by screening seems to affect early morbidity.

Identificador

http://eprints.qut.edu.au/90833/

Publicador

BMJ Publishing Group Ltd

Relação

DOI:10.1136/adc.63.2.196

Bowling, F., Cleghorn, G.J., Chester, A., Curran, J., Griffin, B., Prado, J., Francis, P., & Shepherd, R. (1988) Neonatal screening for cystic fibrosis. Archives of Disease in Childhood, 63(2), pp. 196-198.

Fonte

Faculty of Health; Institute of Health and Biomedical Innovation

Palavras-Chave #controlled study #cystic fibrosis #human #immunoreactive trypsin #newborn #review #weight gain #Body Weight #Comparative Study #Follow-Up Studies #Infant #Newborn #Mass Screening #Queensland #Time Factors
Tipo

Journal Article